NCT00630968View on ClinicalTrials.gov

S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy

PHASE4CompletedINTERVENTIONAL

Enrollment

1,541

Participants

Timeline

Start Date

August 31, 2000

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions

Epilepsy

Interventions

DRUG

Levetiracetam (Keppra)

Sponsors

Lead Sponsor

All Listed Sponsors

lead

UCB Pharma

INDUSTRY